Development and engineering of lymphatic endothelial cells: Clinical implications

Current Pharmaceutical Design

Volumn 10, Issue 1, 2004, Pages 75-80

  Wilting, Jörg ^a   Schweigerer, Lothar ^a  

^a Department of Pediatrics and Neuropediatrics   (Germany)

Author keywords

Angiosarcoma; Lymphangiogenesis; Lymphangiogenic growth factors; Lymphangioma; Lymphedema

Indexed keywords

CD34 ANTIGEN; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; VASCULOTROPIN C; VASCULOTROPIN D; VASCULOTROPIN RECEPTOR 2; VASCULOTROPIN RECEPTOR 3;

ANGIOGENESIS; ANGIOSARCOMA; APLASIA; BLOOD VESSEL; CELL DIFFERENTIATION; CELL SPECIFICITY; DYSPLASIA; EMBRYO DEVELOPMENT; ENDOTHELIUM CELL; GENE FUNCTION; GENETIC ENGINEERING; HUMAN; HYPOPLASIA; KAPOSI SARCOMA; LYMPH NODE HYPERPLASIA; LYMPH NODE METASTASIS; LYMPH VESSEL; LYMPHATIC DRAINAGE; LYMPHATIC SYSTEM; LYMPHEDEMA; NONHUMAN; PRIORITY JOURNAL; REVIEW; VASCULAR ENDOTHELIUM;

ANGIODYSPLASIA; ANIMALS; CELL DIFFERENTIATION; ENDOTHELIAL CELLS; HEMANGIOSARCOMA; HUMANS; LYMPHANGIOGENESIS; LYMPHANGIOMA; LYMPHATIC VESSELS; LYMPHEDEMA; LYMPHOKINES; NEOVASCULARIZATION, PATHOLOGIC; SARCOMA, KAPOSI; SYNDROME;

EID: 0347286789     PISSN: 13816128     EISSN: None     Source Type: Journal    
DOI: 10.2174/1381612043453577     Document Type: Review

References (80)

1. Asellius G. De Lacteibus sive lacteis venis Quarto Vasorum Mesaroicum genere novo invente Gasp. Asellii Cremonesis Antomici Ticiensis Qua Sententiae Anatomicae multae, nel perperam receptae illustrantur. Mediolani, apud Jo. Baptistam Bidellium 1627.
2. Pecquet J. Experimenta nova anatomica, quibus incognitum chyli receptaculum et ab eo per thoracem in ramos usque subclavios vasa lactea deteguntur. Montpelier 1651.
3. Kampmeier OF. Evolution and comparative morphology of the lymphatic system. Illinois, Springfield; Charles C. Thomas 1969; p 1-620.
4. Schmid-Schönbein GW. The second valve system in lymphatics. Lyph Res Biol 2003; 1: 25-9.
5. Gannon BJ, Carati CJ. Endothelial distribution of the membrane water channel molecule Aquaporin-1: implications for tissue and lymph fluid physiology? Lymph Res Biol 2003; 1: 55-66.
6. Casley-Smith JR. The fine structure and functioning of tissue channels and lymphatics. Lymphology 1980; 12: 177-83.
7. Wilting J. Integrated vascular anatomy. In: Panvascular medicine. Lanzer P, Topol EJ (eds) Springer, Heidelberg 2002; p 50-75.
8. Schmid-Schönbein GW. Microlymphatics and lymph flow. Physiol Rev 1990; 70: 987-1028.
9. Ji RC, Kato S. Histochemical analysis of lymphatic endothelial cells in lymphostasis. Micr Res Tech 2001; 55: 70-80.
10. Witte MH, Bernas MJ, Martin CP, Witte CL. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Micr Res Tech 2001; 55: 122-45.
11. Irrthum A, Karkkainen MJ, Devriendt K, Alitalo K, Vikkula M. Congenital hereditary lymphedema caused by a mutation that inactivates VEGFR3 tyrosine kinase. Am J Hum Genet 2000; 67: 295-301.
12. Karkkainen MJ, Ferrell RE, Lawrence EC, Kimak MA, Levinson KL, McTigue MA, et al. Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema. Nat Genet 2000; 25: 153-59.
13. Dale RF. The inheritance of primary lymphedema. J Med Genet 1985; 22: 274-78.
14. Fang JM, Dagenais SL, Erickson RP, Ant MF, Glynn MW, Gorski JL, et al. Mutations in FOXC2 (MFH-1), a forkhead family transcription factor, are responsible for the hereditary lymphedema-distichiasis syndrome. Am J Hum Genet 2000; 67: 1382-88.
15. Erickson RP. Forkhead genes and human disease. J Appl Genet 2001; 42: 211-21.
16. Sudo H, Tonegawa A, Yoshiko A, Aoyama H, Mizutani-Koseki Y, Moriya H, et al. Inductive signals from the somatopleure mediated by bone morphogenetic proteins are essential for the formation of the sternal component of avian ribs. Dev Biol 2001; 232: 284-300.
17. Mulliken, JB, Young AE. Vascular birthmarks. Philadelphia, WB. Saunders, 1988.
18. Wilting J, Papoutsi M, Christ B, Nicolaides KH, von Kaisenberg CS, Borges J, et al. The transcription factor Prox1 is a marker for lymphatic endothelial cells in normal and diseased tissues. FASEB J 2002; 16: 1271-3.
19. Olszewsky W. The lymphatic system in body homeostasis: physiological conditions. Lymphat Res Biol 2003; 1: 11-21.
20. Albini A, Barillari G, Benelli R, Gallo RC, Ensoli B. Angiogenic properties of human immunodeficiency virus type 1 Tat protein. Proc Natl Acad Sci USA 1995; 92: 4838-42.
21. Dictor M, Rambech E, Way D, Witte M, Bendsoe N. Human herpesvirus 8 (KSHV) DNA in Kaposi's sarcoma lesions, AIDS Kaposi's sarcoma cell lines, endothelial Kaposi's sarcoma simulators, and the skin of immunosuppressed patients: A molecular epidemiologic study. Am J Pathol 1996; 148: 2009-16.
22. Munshi N, Ganju R, Avraham S, Mesri E, Groopman J. Kaposi's sarcoma associated herpes-encoded G protein coupled receptor activation of c-jun amino-terminal kinase/stress-activated protein kinase and lyn kinase is mediated by related adhesion focal tyrosine kinase/proline-rich tyrosine kinase 2. J Biol Chem 1999; 274: 31863-7.
23. Partanen TA, Paavonen K. Lymphatic versus blood vascular endothelial growth factors and receptors in humans. Micr Res Tech 2001; 55: 108-21.
24. Folkman J. Tumor angiogenesis factors. Cancer Res 1974; 34: 2109-13.
25. Papoutsi M, Siemeister G, Weindel K, Tomarev SI, Kurz H, Schächtele C, et al. Active interaction of human A375 melanoma cells with the lymphatics in vivo. Histochem Cell Biol 2000; 114: 373-85.
26. Mandriota SJ, Jussila L, Jeltsch M, Compagni A, Baetens D, Prevo R, et al. Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis. EMBO J 2001; 20: 672-82.
27. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Velasco P, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001; 7: 192-98.
28. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, et al. VEGF-D promotes the metastatitic spread of tumor cells via the lymphatics. Nat Med 2001; 7: 186-91.
29. Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. Micr Res Tech 2001; 55: 92-9.
30. Krishnan J, Kirkin V, Steffen A, Hegen M, Weih D, Tomarev S, et al. Differential in Vivo and in Vitro Expression of Vascular Endothelial Growth Factor (VEGF)-C and VEGF-D in Tumors and Its Relationship to Lymphatic Metastasis in Immunocompetent Rats. Cancer Res 2003; 63: 713-22.
31. Sabin FR. On the origin of the lymphatic system from the veins and the development of the lymph hearts and thoracic duct in the pig. Am J Anat 1902; 1: 367-89.
32. Sabin FR. The lymphatic system in human embryos, with a consideration of the system as a whole. Am J Anat 1909; 9: 43-9.
33. Huntington GS, McClure C. The anatomy and development of the jugular lymph sacs in the domestic cat. Anat Rec 1908; 2: 1-18.
34. Mc Clure C. The development of the thoracic and right lymphatic ducts in the domestic cat (Felis domestica). Anat Anz 1908; 32: 533-43.
35. Kampmeier OF. The value of the injection method in the study of lymphatic development. Anat Rec 1912; 6: 223-33.
36. Van der Putte SCJ. The development of the lymphatic system in man. Adv Anat Embryol Cell Biol 1975; 51: 1-60.
37. Huntington GS. The genetic relations of lymphatic and haemal vascular channels in the embryos of amniotes. Am S Anat 1914; 16: 259-316.
38. Davis H. A statistical study of the thoracic duct in man. Am J Anat 1915; 17: 211-44.
39. Kinnaert P. Anatomical variations of the cervical portion of the thoracic duct in man. J Anat 1973; 115: 45-52.
40. Langer C. Ueber das Lymphgefaesssystem des Frosches. Abh Acad Wiss Wien, Math-naturwiss K1 1866; 53: 395-422.
41. Ranvier L. Morphologie et développement des vaisseaux lymphatique chez les mammifères. Archives Anat Microsc 1897; 1: 69-81.
42. Sabin FR. A critical study on the evidence presented in several recent articles on the development of the lymphatic system. Anat Rec 1911; 5: 417-46.
43. Wigle JT, Oliver G. Prox1 function is required for the development of the murine lymphatic system. Cell 1999; 98: 769-78.
44. Wigle JT, Harvey N, Detmar M, Lagutina I, Grosveld G, Gunn MD, et al. An essential role for Prox1 in the induction of the lymphatic endothelial cell phenotype. EMBO J 2002; 21: 1505-13.
45. Schneider M, Othman-Hassan K, Christ B, Wilting J. Lymphangioblasts in the avian wing bud. Dev Dyn 1999; 216: 311-19.
46. Papoutsi M, Tomarev SI, Eichmann A, Pröls F, Christ B, Wilting J. Endogenous origin of the lymphatics in the avian chorioallantoic membrane. Dev Dyn 2001; 222: 238-51.
47. Wilting J, Papoutsi M, Schneider M, Christ B. The lymphatic endothelium of the avian wing is of somitic origin. Dev Dyn 2000; 217: 271-8.
48. Wilting J, Tomarev SI, Christ B, Schweigerer L. Lymphangioblasts in embryonic lymphangiogenesis. Lymphat Res Biol 2003; 1: 33-40.
49. + lymphatic/vascular endothelial precursor cells Blood 2003; 101: 168-72.
50. Sleeman J, Krishnan J, Kirkin V, Baumann P. Markers for the lymphatic endothelium; in search of the holy grail? Micr Res Tech 2001; 55: 61-9.
51. Wilting J, Papoutsi M, Othman-Hassan K, Rodriguez-Niedenführ M, Pröls F, Tomarev SI, et al. Development of the avian lymphatic system. Microsc Res Tech 2001; 55: 81-91.
52. Seifert R, Zhao B, Christ. B. Cytokinetic studies on the aortic endothelium and limb bud vascularization in avian embryos. Anat Embryol 1992; 186: 601-10.
53. Kriehuber E, Breiteneder-Geleff S, Groeger M, Soleiman A, Schoppmann SF, Stingl G, et al. Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages. J Exp Med 2001; 194: 797-808.
54. Pullinger DB, Florey HW. Proliferation of lymphatics in inflammation. J Pathol Bacteriol 1937; 45: 157-170.
55. Makinen T, Veikkola T, Mustjoki S, Karpanen T, Catimel B, Nice EC, et al. Isolated lymphatic endotheiial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3. EMBO J 2001; 20: 4762-73.
56. Abtahian F, Guerriero A, Sebzda E, Lu MM, Zhou R, Mocsai A, et al. Regulation of blood and lymphatic vascular separation by signaling proteins SLP-76 and Syk. Science 2003; 299: 247-51.
57. Holder N, Klein R. Eph receptors and ephrins: effectors of morphogenesis. Development 1999; 126: 2033-44.
58. Adams RH, Wilkinson GA, Weiss C, Diella F, Gale NW, Deutsch U, et al. Roles of ephrinB ligands and ephB receptors in cardiovascular development: demarcation of arterial/venous domains, vascular morphogenesis, and sprouting angiogenesis. Genes Dev 1999; 13: 295-306.
59. Wang HU, Chen ZF, Anderson DJ Molecular distinction and angiogenic interaction between embryonic arteries and veins revealed by ephrin-B2 and its receptor eph-B4. Cell 1998; 93: 741-53.
60. Wetterwald A, Hoffstefter W, Cecchini MG, Lanske B, Wagner C, Fleisch H, et al. Characterization and cloning of the E11 antigen, a marker expressed by rat osteoblasts and osteocytes. Bone 1996; 18: 125-32.
61. Matsui K, Breiteneder-Geleff S, Kerjaschki D. Epitope-specific antibodies to the 43-kD glomerular membrane protein podoplanin cause proteinuria and rapid flattening of podocytes. J Am Soc Nephrol 1998; 9: 2013-26.
62. Banerji S, Ni J, Wang SX, Clasper S, Su J, Tammi R, et al. LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan. J Cell Biol 1999; 144: 789-801.
63. Haak MC, Bartelings MM, Jackson DG, Webb S, van Vugt JMG, Gittenberger-de Groot AC. Increased nuchal translucency is associated with jugular lymphatic distension. Hum Repro 2002; 17: 1086-92.
64. Jeltsch MM, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997; 276: 1423-5.
65. Oh SJ, Jeltsch MM, Birkenhäger R, McCarthy JEG, Weich HA, Christ B, et al. VEGF and VEGF-C: Specific induction of angiogenesis and lymphangiogenesis in the differenciated avian chorioallantoic membrane. Dev Biol 1997; 188: 96-109.
66. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4). Proc Natl Acad Sci USA 1998; 95: 548-53.
67. Joukov V, Pajusola K, Kaipainen A, Chilov D, Lahtinen I, Kukk E, et al. A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J 1996; 15: 290-8.
68. Stacker SA, Stenvers K, Caesar C, Vitali A, Domagala T, Nice E, et al. Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers. J Biol Chem 1999; 274: 32127-36.
69. Saaristo A, Karkkainen MJ, Alitalo K. Insights into the molecular pathogenesis and targeted treatment of lymphedema. Ann N Y Acad Sci 2002; 979: 94-110.
70. Karkkainen MJ, Saaristo A, Jussila L, Karila KA, Lawrence EC, Pajusola K, et al. A model for gene therapy of human hereditary lymphedema. Proc Natl Acad Sci USA 2001; 98: 12677-82.
71. Szuba A, Skobe M, Karkkainen MJ, Shin WS, Beynet DP, Rockson NB, et al. Therapeutic lymphangiogenesis with human recombinant VEGF-C. FASEB J 2002; 16: 1985-7.
72. Hellman T. Lymphgefaesse, Lymphknoetchen und Lymphknoten. I. Die Lymphgefaesse, die Lymphbahnen. In: Handbuch der mikroskopischen Anatomie des Menschen. (von Moellendorff W, ed.) Berlin: Springer Verlag 1930; 233-82.
73. Petrova TV, Mäkinen T, Mäkela TP, Saarela J, Virtanen I, Ferrell RE, et al. Lymphatic endothelial reprogramming of vascular endothelial cells by the Prox-1 homeobox transcription factor. EMBO J 2002; 21: 4593-9.
74. Hong YK, Harvey N, Noh YH, Schacht V, Hirakawa S, Detmar M, et al. Prox1 is a master control gene in the program specifying lymphatic endothelial cell fate. Dev Dyn 2002; 225: 351-7.
75. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, et al. Isolation of putative progenitor endothelial cells for agiogenesis. Science 1997; 275: 964-7.
76. Lyden D, Hattori K, Dias S, Costa C, Blaikie P, Butros L, et al. Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth. Nat Med 2001; 7: 1194-201.
77. Van Damme A, Vanden Driessche T, Collen D, Chuah MK. Bone marrow stromal cells as targets for gene therapy. Curr Gene Ther 2002; 2: 195-209.
78. Burchmore RJ, Ogbunude PO, Enanga B, Barrett MP. Chemotherapy of human African trypanosomiasis. Curr Pharm Design 2002; 8(4): 256-67.
79. Kurowska EM. Nitric oxide therapies in vascular diseases. Curr Pharm Design 2002; 8(3): 155-66.
80. MacDonald KP, Hill GR. Keratinocyte Growth Factor (KGF) in hematology and oncology. Curr Pharm Design 2002; 8(5): 395-403.